PHARMASENSE: what changed
Two fiscal years side by side, explained: what moved most in the balance sheet and the result, why the result rose or fell, and where the money went.
PHARMASENSE
Largest movements
- Cash -€68,421
down €68,421 (-100.0%), from €68,426 to €5
mainly Current portion of long-term debt (-€83,415) and Receivables within one year (-€46,043)
- Receivables within one year +€46,043
up €46,043 (+250.0%), from €18,416 to €64,459
of which Trade receivables: +€47,459
- Reserves +€157,945
up €157,945 (+14.6%), from €1.1m to €1.2m
- Current portion of long-term debt -€83,415
down €83,415 (-67.2%), from €124,085 to €40,670
- Debts after one year -€40,670
down €40,670 (-12.5%), from €325,128 to €284,458
- Other debts -€39,005
down €39,005 (-11.5%), from €338,481 to €299,476
- Gross operating margin +€9,234
up €9,234 (+3.9%), from €234,437 to €243,670
- Financial charges -€5,422
down €5,422 (-26.7%), from €20,312 to €14,890
- Taxes +€2,999
up €2,999 (+4.6%), from €65,000 to €67,999
From the 2024 result to the 2025 result
Each bar is the change in one income-statement line, as its effect on the result: higher costs pull it down, higher income lifts it.
Cash bridge derived
Derived from the 2024 and 2025 balance sheets and the 2025 result: not a filed cash-flow statement. It shows where the money came from and went.
Every line side by side
| Line | Code | 2024 | 2025 | Change | % |
|---|---|---|---|---|---|
| Total assets | 20/58 | €1,935,616 | €1,929,982 | -€5,634 | -0.3% |
| Fixed assets | 21/28 | €1,848,774 | €1,865,518 | +€16,744 | +0.9% |
| Tangible fixed assets | 22/27 | - | €16,744 | +€16,744 | |
| Other tangible fixed assets | 26 | - | €16,744 | +€16,744 | |
| Financial fixed assets | 28 | €1,848,774 | €1,848,774 | = | 0.0% |
| Current assets | 29/58 | €86,842 | €64,465 | -€22,378 | -25.8% |
| Amounts receivable within one year | 40/41 | €18,416 | €64,459 | +€46,043 | +250.0% |
| Trade receivables | 40 | - | €47,459 | +€47,459 | |
| Other amounts receivable | 41 | €18,416 | €17,000 | -€1,416 | -7.7% |
| Cash at bank and in hand | 54/58 | €68,426 | €5 | -€68,421 | -100.0% |
| Total equity and liabilities | 10/49 | €1,935,616 | €1,929,982 | -€5,634 | -0.3% |
| Equity | 10/15 | €1,097,586 | €1,255,532 | +€157,945 | +14.4% |
| Contributions | 10/11 | €18,600 | €18,600 | = | 0.0% |
| Reserves | 13 | €1,078,986 | €1,236,932 | +€157,945 | +14.6% |
| Distributable reserves | 133 | €1,078,986 | €1,236,932 | +€157,945 | +14.6% |
| Amounts payable | 17/49 | €838,030 | €674,451 | -€163,579 | -19.5% |
| Amounts payable after more than one year | 17 | €325,128 | €284,458 | -€40,670 | -12.5% |
| Financial debts | 170/4 | €325,128 | €284,458 | -€40,670 | -12.5% |
| Amounts payable within one year | 42/48 | €506,002 | €386,543 | -€119,459 | -23.6% |
| Current portion of amounts payable after more than one year | 42 | €124,085 | €40,670 | -€83,415 | -67.2% |
| Financial debts | 43 | €25,505 | €25,365 | -€140 | -0.5% |
| Other loans | 439 | €25,505 | €25,365 | -€140 | -0.5% |
| Trade debts | 44 | €1,927 | €3,952 | +€2,025 | +105.1% |
| Suppliers | 440/4 | €1,927 | €3,952 | +€2,025 | +105.1% |
| Taxes, remuneration and social security | 45 | €16,005 | €17,080 | +€1,076 | +6.7% |
| Taxes | 450/3 | €16,005 | €17,080 | +€1,076 | +6.7% |
| Other amounts payable | 47/48 | €338,481 | €299,476 | -€39,005 | -11.5% |
| Accrued charges and deferred income | 492/3 | €6,900 | €3,450 | -€3,450 | -50.0% |
| Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets | 630 | - | €1,737 | +€1,737 | |
| Other operating charges | 640/8 | €118 | €1,099 | +€981 | +831.5% |
| Gross operating margin | 9900 | €234,437 | €243,670 | +€9,234 | +3.9% |
| Operating profit (loss) | 9901 | €234,319 | €240,835 | +€6,516 | +2.8% |
| Financial charges | 65/66B | €20,312 | €14,890 | -€5,422 | -26.7% |
| Recurring financial charges | 65 | €20,312 | €14,890 | -€5,422 | -26.7% |
| Profit (loss) for the period before taxes | 9903 | €214,006 | €225,944 | +€11,938 | +5.6% |
| Income taxes | 67/77 | €65,000 | €67,999 | +€2,999 | +4.6% |
| Profit (loss) for the period | 9904 | €149,006 | €157,945 | +€8,939 | +6.0% |
| Profit (loss) for the period to be appropriated | 9905 | €149,006 | €157,945 | +€8,939 | +6.0% |
Source: filed annual accounts (NBB), fiscal years ended 31 December 2024 and 31 December 2025. Colour: green is a favourable move for that line, red an unfavourable one. Prepared on 7 October 2026 via checked.be.